Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Oct;110(Suppl 5):729–731. doi: 10.1289/ehp.02110s5729

Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).

Anatoly Zhitkovich 1, George Quievryn 1, Joseph Messer 1, Zhanna Motylevich 1
PMCID: PMC1241234  PMID: 12426121

Abstract

Induction of DNA damage by carcinogenic hexavalent chromium compounds [Cr(VI)] results from its reduction to lower oxidation states. Reductive metabolism of Cr(VI) generates intermediate Cr(V/IV)species, organic radicals, and finally Cr(III), which forms stable complexes with many biological ligands, including DNA. To determine the biological significance of different reaction products, we examined genotoxic responses and the formation of DNA damage during reduction of Cr(VI) by its biological reducer, cysteine. We have found that cysteine-dependent activation of Cr(VI) led to the formation of Cr-DNA and cysteine-Cr-DNA adducts as well as interstrand DNA cross-links. The yield of binary and ternary DNA adducts was relatively constant at different concentrations of Cr(VI) and averaged approximately 54 and 45%, respectively. Interstrand DNA cross-links accounted on average for 1% of adducts, and their yield was even less significant at low Cr(VI) concentrations. Reduction of Cr(VI) in several commonly used buffers did not induce detectable damage to the sugar-phosphate backbone of DNA. Replication of Cr(VI)-modified plasmids in intact human fibroblasts has shown that cysteine-dependent metabolism of Cr(VI) resulted in the formation of mutagenic and replication-blocking DNA lesions. Selective elimination of Cr-DNA adducts from Cr(VI)-treated plasmids abolished all genotoxic responses, indicating that nonoxidative, Cr(III)-dependent reactions were responsible for the induction of both mutagenicity and replication blockage by Cr(VI). The demonstration of the mutagenic potential of Cr-DNA adducts suggests that these lesions can be explored in the development of specific and mechanistically important biomarkers of exposure to toxic forms of Cr.

Full Text

The Full Text of this article is available as a PDF (123.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiyar J., Berkovits H. J., Floyd R. A., Wetterhahn K. E. Reaction of chromium (VI) with hydrogen peroxide in the presence of glutathione: reactive intermediates and resulting DNA damage. Chem Res Toxicol. 1990 Nov-Dec;3(6):595–603. doi: 10.1021/tx00018a016. [DOI] [PubMed] [Google Scholar]
  2. Bridgewater L. C., Manning F. C., Patierno S. R. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking. Carcinogenesis. 1994 Nov;15(11):2421–2427. doi: 10.1093/carcin/15.11.2421. [DOI] [PubMed] [Google Scholar]
  3. Lafleur M. V., Retèl J. Contrasting effects of SH-compounds on oxidative DNA damage: repair and increase of damage. Mutat Res. 1993 Jan;295(1):1–10. doi: 10.1016/0921-8734(93)90006-o. [DOI] [PubMed] [Google Scholar]
  4. Landolph J. R. Role of free radicals in metal-induced carcinogenesis. Met Ions Biol Syst. 1999;36:445–483. [PubMed] [Google Scholar]
  5. O'Brien T., Xu J., Patierno S. R. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest. Mol Cell Biochem. 2001 Jun;222(1-2):173–182. [PubMed] [Google Scholar]
  6. Quievryn G., Goulart M., Messer J., Zhitkovich A. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates. Mol Cell Biochem. 2001 Jun;222(1-2):107–118. [PubMed] [Google Scholar]
  7. Shi X., Dong Z., Dalal N. S., Gannett P. M. Chromate-mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid hydroperoxides. Biochim Biophys Acta. 1994 Apr 12;1226(1):65–72. doi: 10.1016/0925-4439(94)90060-4. [DOI] [PubMed] [Google Scholar]
  8. Snow E. T. Metal carcinogenesis: mechanistic implications. Pharmacol Ther. 1992;53(1):31–65. doi: 10.1016/0163-7258(92)90043-y. [DOI] [PubMed] [Google Scholar]
  9. Sorahan T., Burges D. C., Hamilton L., Harrington J. M. Lung cancer mortality in nickel/chromium platers, 1946-95. Occup Environ Med. 1998 Apr;55(4):236–242. doi: 10.1136/oem.55.4.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Standeven A. M., Wetterhahn K. E. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis. 1992 Aug;13(8):1319–1324. doi: 10.1093/carcin/13.8.1319. [DOI] [PubMed] [Google Scholar]
  11. Stearns D. M., Wetterhahn K. E. Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem Res Toxicol. 1994 Mar-Apr;7(2):219–230. doi: 10.1021/tx00038a016. [DOI] [PubMed] [Google Scholar]
  12. Sugden K. D., Stearns D. M. The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer. J Environ Pathol Toxicol Oncol. 2000;19(3):215–230. [PubMed] [Google Scholar]
  13. Suzuki Y., Fukuda K. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch Toxicol. 1990;64(3):169–176. doi: 10.1007/BF02010721. [DOI] [PubMed] [Google Scholar]
  14. Voitkun V., Zhitkovich A., Costa M. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res. 1998 Apr 15;26(8):2024–2030. doi: 10.1093/nar/26.8.2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yuann J. M., Liu K. J., Hamilton J. W., Wetterhahn K. E. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI). Carcinogenesis. 1999 Jul;20(7):1267–1275. doi: 10.1093/carcin/20.7.1267. [DOI] [PubMed] [Google Scholar]
  16. Zhitkovich A., Shrager S., Messer J. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage. Chem Res Toxicol. 2000 Nov;13(11):1114–1124. doi: 10.1021/tx0001169. [DOI] [PubMed] [Google Scholar]
  17. Zhitkovich A., Song Y., Quievryn G., Voitkun V. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry. 2001 Jan 16;40(2):549–560. doi: 10.1021/bi0015459. [DOI] [PubMed] [Google Scholar]
  18. Zhitkovich A., Voitkun V., Costa M. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis. 1995 Apr;16(4):907–913. doi: 10.1093/carcin/16.4.907. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES